The effect of resveratrol on the prevention of cisplatin ototoxicity

European Archives of Oto-Rhino-Laryngology

Volumn 269, Issue 10, 2012, Pages 2185-2188

  Erdem, T ^a   Bayindir, Tuba ^a   Filiz, A ^b   Iraz, M ^c   Selimoglu, E ^a  

^a Anönü University   (Turkey)

^b Zekai Tahir Obstetrics and Gynecology Hospital   (Turkey)

^c Bezmi Alem University   (Turkey)

Author keywords

Antioxidant agent; Cisplatin; Ototoxicity; Resveratrol

Indexed keywords

ALCOHOL; CISPLATIN; KETAMINE; RESVERATROL; SODIUM CHLORIDE; XYLAZINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG EFFECT; EXPERIMENTAL STUDY; FEMALE; FREQUENCY MODULATION; GENERAL ANESTHESIA; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; WISTAR ALBINO GLAXO RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS, SENSORINEURAL; OTOACOUSTIC EMISSIONS, SPONTANEOUS; OXIDATIVE STRESS; RATS; RATS, WISTAR; STILBENES;

EID: 84867242436     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1883-5     Document Type: Article

References (22)

1. McKeage MJ (1995) Comparative adverse effects of platinum drugs. Drug Safety 13:228-244
2. Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: The inXuence of age and the cumulative dose. Eur J Cancer 40:2445-2451
3. Knight KRG, Kraemer DF, Neuwelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may inXuence academic and social development. J Clin Oncol 23:8588-8896
4. Chen WC, Jackson A, Budnick AS, PWster DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL (2006) Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 106:820-829
5. Huang X, Whitworth CA, Rybak LP (2007) Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28:828-833
6. Reiter RJ, Tan DX, Korkmaz A, Fuentes-Broto L (2011) Drugmediated ototoxicity and tinnitus: Alleviation with melatonin. J Physiol Pharmacol 62:151-157
7. Giordano P, Lorito G, Ciorba A, Martini A, Hatzopoulos S (2006) Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model. Acta Otorhinolaryngol Ital 26:198-207
8. Campbell KC, Meech RP, Klemens JJ, Gerberi MT, Dyrstad SS, Larsen DL, Mitchell DL, El-Azizi M, Verhulst SJ, Hughes LF (2007) Prevention of noise-and drug-induced hearing loss with D-methionine. Hear Res 226:92-103
9. Hyppolito MA, de Oliveira JA, Rossato M (2006) Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol 263:798-803
10. Breuil AC, Jeandet P, Adrian M, Chopin F, Pirio N, Meunier P, Bessis R (1999) Characterization of a pterostilbene dehydrodimer produced by laccase of Botrytis cinerea. Phytopathology 89:298-302
11. Savouret JF, Quesne M (2002) Resveratrol and cancer: A review. Biomed Pharmacother 56:84-87
12. Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: Antioxidant defense system. Pharmacol Toxicol 76: 386-394
13. Tsukasaki N, Whitworth CA, Rybak LP (2000) Acute changes in cochlear potentials due to cisplatin. Hear Res 149:189-198
14. Klis SF, O'Leary SJ, Hamers FP, De Groot JC, Smoorenburg GF (2000) Reversible cisplatin ototoxicity in the albino guinea pig. Neuroreport 11:623-626
15. Van Ruijven MWM, de Groot JCMJ, Klis SFL, Smoorenburg G (2005) Cochlear targets of cisplatin: An electrophysiological and morphological time-sequence study. Hear Res 205:241-248
16. Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T, Takasaka T (2000) Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res 141:28-38
17. Clerici WJ, DiMartino DL, Prasad MR (1995) Direct effect of reactive oxygen species on cochlear outer hair cells. Hear Res 84:30-40
18. Clerici WJ, Hensley K, DiMartino DL, ButterWeld DA (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98:116-124
19. Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Spray D, Garcia P, Steinman H, Malgrange B, Ruben RJ, Rybak L, Van de Water T (1997) The use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin induced damage of auditory hair cells. Am J Otol 18:559-571
20. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H (2001) Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27-34
21. Bonabi S, Caelers A, Monge A, Huber A, Bodmer D (2008) Resveratrol protects auditory hair cells from gentamicin toxicity. Ear Nose Throat J 87:570-573
22. Seidman M, Babu S, Tang W, Naem E, Quirk WS (2003) EVects of resveratrol on acoustic trauma. Otolaryngol Head Neck Surg 129:463-470